Overview

A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults

Status:
Completed
Trial end date:
2007-05-15
Target enrollment:
Participant gender:
Summary
GW679769 may affect liver enzymes that metabolize dexamethasone and ondansetron. This study is designed to test the safety and the extent of the GW679769 affect on dexamethasone and ondansetron levels in humans.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
BB 1101
Casopitant
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Ondansetron